Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Looking for participantsNCT04901702What this trial is testingStudy of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaWho this might be right forRecurrent Solid TumorRecurrent Ewing SarcomaRecurrent Hepatoblastoma+19 more St. Jude Children's Research Hospital 90
Early research (Phase 1)Study completedNCT01445379What this trial is testingPhase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerWho this might be right forSarcomaWilm's TumorLymphoma+1 more National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00931931What this trial is testingHSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsWho this might be right forRhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more Timothy Cripe 18
Large-scale testing (Phase 3)Study completedNCT00008359What this trial is testingCaspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00036959What this trial is testingABT-751 in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994What this trial is testingUlixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704What this trial is testingLarotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT05302921What this trial is testingNeoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid TumorsWho this might be right forOsteosarcomaEwing SarcomaRhabdomyosarcoma+7 more Children's National Research Institute 5
Testing effectiveness (Phase 2)Study completedNCT03213665What this trial is testingTazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more National Cancer Institute (NCI) 20
Not applicableStudy completedNCT02162732What this trial is testingMolecular-Guided Therapy for Childhood CancerWho this might be right forNeuroblastomaMedulloblastomaGlioma+16 more Giselle Sholler 186
Early research (Phase 1)WithdrawnNCT01236586What this trial is testingRO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forLymphomaBrain NeoplasmsSarcoma+2 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT04483778What this trial is testingB7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsWho this might be right forPediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more Seattle Children's Hospital 68
Early research (Phase 1)Study completedNCT03507491What this trial is testingNab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsWho this might be right forCancer Emory University 24
Testing effectiveness (Phase 2)WithdrawnNCT02689336What this trial is testingErlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWho this might be right forGliomaRhabdomyosarcomaOsteosarcoma+5 more Washington University School of Medicine
Early research (Phase 1)Study completedNCT01132911What this trial is testingA Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and LymphomasWho this might be right forLymphomaSarcomaWilmsTumor+1 more National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00331643What this trial is testingIxabepilone in Treating Young Patients With Refractory Solid TumorsWho this might be right forAdult RhabdomyosarcomaAdult Synovial SarcomaAlveolar Childhood Rhabdomyosarcoma+10 more National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40